| Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study R Sheehan, A Hassiotis, K Walters, D Osborn, A Strydom, L Horsfall Bmj 351, 2015 | 462 | 2015 |
| Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study R Sheehan, L Horsfall, A Strydom, D Osborn, K Walters, A Hassiotis BMJ open 7 (8), e017406, 2017 | 113 | 2017 |
| Dementia diagnostic criteria in Down syndrome R Sheehan, A Sinai, N Bass, P Blatchford, I Bohnen, S Bonell, ... International journal of geriatric psychiatry 30 (8), 857-863, 2015 | 105 | 2015 |
| Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review R Sheehan, A Hassiotis The Lancet Psychiatry 4 (3), 238-256, 2017 | 103 | 2017 |
| Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome CM Startin, S Hamburg, R Hithersay, T Al-Janabi, KY Mok, J Hardy, ... Alzheimer's & Dementia 15 (2), 245-257, 2019 | 85 | 2019 |
| Digital mental health and intellectual disabilities: state of the evidence and future directions R Sheehan, A Hassiotis BMJ Ment Health 20 (4), 107-111, 2017 | 83 | 2017 |
| Dementia in intellectual disability R Sheehan, A Ali, A Hassiotis Current Opinion in Psychiatry 27 (2), 143-148, 2014 | 46 | 2014 |
| Learning from lives and deaths-people with a learning disability and autistic people (Leder) report for 2022 A White, R Sheehan, J Ding, C Roberts, N Magill, R Keagan-Bull, B Carter, ... King's College London, 2023 | 41 | 2023 |
| Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study N Eady, R Sheehan, K Rantell, A Sinai, J Bernal, I Bohnen, S Bonell, ... The British Journal of Psychiatry 212 (3), 155-160, 2018 | 41 | 2018 |
| Psychotropic prescribing in people with intellectual disability and challenging behaviour R Sheehan, A Strydom, N Morant, E Pappa, A Hassiotis Bmj 358, 2017 | 39 | 2017 |
| A structured programme to withdraw antipsychotics among adults with intellectual disabilities: the Cornwall experience R Shankar, M Wilcock, S Deb, R Goodey, E Corson, C Pretorius, G Praed, ... Journal of Applied Research in Intellectual Disabilities 32 (6), 1389-1400, 2019 | 33 | 2019 |
| Association of focused medication review with optimization of psychotropic drug prescribing: a systematic review and meta-analysis R Sheehan, A Strydom, E Brown, L Marston, A Hassiotis JAMA Network Open 1 (6), e183750-e183750, 2018 | 30 | 2018 |
| Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and/or autism R Shankar, M Wilcock, K Oak, P McGowan, R Sheehan Drug and Therapeutics Bulletin 57 (1), 10-13, 2019 | 29 | 2019 |
| An audit of the quality of inpatient care for adults with learning disability in the UK R Sheehan, A Gandesha, A Hassiotis, P Gallagher, M Burnell, G Jones, ... BMJ open 6 (4), e010480, 2016 | 29 | 2016 |
| UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism S Deb, T Nancarrow, B Limbu, R Sheehan, M Wilcock, D Branford, ... BJPsych open 6 (5), e112, 2020 | 28 | 2020 |
| Findings from an online survey of family carer experience of the management of challenging behaviour in people with intellectual disabilities, with a focus on the use of … R Sheehan, K Kimona, A Giles, V Cooper, A Hassiotis British Journal of Learning Disabilities 46 (2), 82-91, 2018 | 28 | 2018 |
| Effects of the COVID-19 pandemic on mental healthcare and services: results of a UK survey of front-line staff working with people with intellectual disability and/or autism R Sheehan, C Dalton-Locke, A Ali, NV San Juan, V Totsika, A Hassiotis BJPsych Bulletin 46 (4), 201-207, 2022 | 22 | 2022 |
| Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK R Sheehan, A Hassiotis, A Strydom, N Morant BMJ open 9 (11), e032861, 2019 | 21 | 2019 |
| Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapy RIS Good, A McGarrity, R Sheehan, TE James, H Miller, J Stephens, ... Platelets 26 (1), 17-24, 2015 | 20 | 2015 |
| A comparison of different models to meet the mental health needs of adults with intellectual disabilities R Sheehan, D Paschos Advances in Mental Health and Intellectual Disabilities 7 (3), 161-168, 2013 | 20 | 2013 |
